Longevity Digest — July 5–12, 2026

Blueprint founder Bryan Johnson turned an autoimmune-gastritis diagnosis into a high-resolution personal measurement project. Harvard Medical School genetics professor David Sinclair returned to fasting, resveratrol, and OSK reprogramming after a quiet stretch on X. FoundMyFitness founder Dr. Rhonda Patrick stayed closer to day-to-day protocols, with sleep restriction, flavanols, and post-travel recovery. Physician and The Peter Attia Drive host Peter Attia had a quieter week, but his sleep article sharpened the same question running through the whole digest: which claims are causal enough to act on? 12345

The practical split is narrow. Sleep consistency, sleep quantity, flavanol-rich foods, recovery basics, and resistance training are ready for personal review. Patient-specific immune sequencing, CAR-T or CAAR-T for autoimmune gastritis, oral reprogramming pills, and public supplement defenses still sit on the investigational side of the ledger.

Bryan Johnson, founder of Blueprint and Immortals, published the lead update for this window on July 8: a 6-step plan to treat autoimmune gastritis, a condition he said was diagnosed in May 2026 after years of persistently low ferritin with normal hemoglobin and hematocrit. 113 Johnson said his anti-parietal cell antibody level was 103 Units/mL, about 5 times the normal level, and that stomach-tissue biopsy showed early atrophy. 1

The new plan matters because it is no longer a simple protocol list. Step 1, which Johnson marked as completed, was single-cell immune sequencing of 1 million immune cells. 1 Step 2 is a second stomach biopsy to capture the live T cells carrying out the attack, then match those cells against the blood immune map. 1 Step 3 is a biweekly blood-testing and wearable-data warning system, because Johnson said he cannot easily feel AIG attacks as symptoms. 1

The leap comes in steps 4 and 5. Johnson said his team will freeze immune cells to create a "Bryan in a dish" model, testing experimental drugs on his own cells before putting them into his body. 1 The proposed therapy paths are repairing the cellular error, teaching immune tolerance, designing smart molecules that shut off rogue cells, and using CAR-T or CAAR-T cells to hunt and eliminate them. 1

Johnson framed the standard-care position as inadequate. His line was: "Standard of care tells you that you can't do anything about it. That's old fashioned." 1 He also wrote that an incurable diagnosis is "a rite of passage for Don't Die" and added, "To overcome death, we have to cure disease." 14

Outside experts made the same case less absolute. Toby Cornish, a gastrointestinal pathologist at the Medical College of Wisconsin, told STAT News that CAR-T is "probably the best line of investigation for finding a cure in autoimmune gastritis," but he also said it is "still very early." 15 Mimi Chang Tan, a Baylor College of Medicine gastroenterologist, told STAT that AIG is "notoriously sneaky," often staying silent for decades before diagnosis. 15

The more useful reader signal is not that Johnson has found a cure. The signal is that even a high-measurement lifestyle can miss disease. Ram Hariharan, a Northeastern University data scientist, put it plainly: "Bryan Johnson is arguably the most measured human alive, and this condition still hid from him for years." 16

Johnson's July 11 "subtraction" post added a counterweight to the experimental therapy thread. He wrote, "People forget what I have subtracted. Removing harm is my best performing longevity therapy," then listed 16 removed exposures or habits, including industrial food chemicals, chronic anger, irregular sleep, loneliness, excess sugar and fat, water pollutants, nicotine, and alcohol. 17 For readers, that is the safer Johnson takeaway this week: removal beats escalation when the escalation depends on therapies that do not yet have public human evidence for AIG.

David Sinclair, Harvard Medical School genetics professor and co-founder of Life Biosciences, released Lifespan S2E3 on July 10, a 68-minute episode focused on practical fasting. 3 The episode covered chrononutrition, time-restricted eating, extended fasting, an autophagy timeline, and common fasting myths. 3 Sinclair also showed his own continuous-glucose-monitor data after 3 days of fasting, with glucose down to 69 mg/dL and a stable curve. 3

His personal protocol remains more aggressive than a generic wellness recommendation. Sinclair said he typically uses an 18:6 eating window from 3 p.m. to 9 p.m., occasionally performs a 3-day fast a few times per year, eats mostly plant-based food, and leans toward one meal a day. 3 His simplest message was, "No complicated rules, no rigid meal plans. It can be really simple." 3

Sinclair's fasting claims still need careful parsing. He cited Valter Longo's 2024 fasting-mimicking-diet work and said 3 cycles reduced biological age by an average of 2.5 years. 3 He also argued that exercise improves healthspan but does not significantly extend maximum lifespan in the way calorie restriction can across multiple species. 3 Those claims belong in the hypothesis-and-evidence lane. They are not a reason for readers to copy a 3-day fast without clinician input, especially if they use glucose-lowering drugs, have a history of disordered eating, are pregnant, or have relevant medical conditions.

The other Sinclair thread was reputational. On July 11, he tweeted, "Still taking resveratrol every morning," a short statement that drew 749 likes and about 125,000 views in the captured data. 6 Later the same day, he shared a study in Clinical Epigenetics and wrote that first-generation clocks largely failed in men with cardiometabolic disease, while GrimAge and DunedinPACE detected accelerated biological aging. 7

He also shared an editor-in-chief article on sirtuins as drug targets and wrote that it covered clinical trials of small-molecule activators such as resveratrol and SRT2104. 18 The article itself was not accessible in the research cache, so the specific clinical-trial claims behind that tweet cannot be evaluated from the available material. The safe reading is narrower: Sinclair publicly maintained his resveratrol position and pointed followers toward sirtuin biology, but the week did not provide new public outcome data that resolves the resveratrol dispute.

On reprogramming, Sinclair posted that there was "Another good reason to use OSK not OSKM to epigenetically rejuvenate." 8 OSK refers to Oct4, Sox2, and Klf4 without c-Myc, while OSKM includes c-Myc, the factor often flagged for oncogenic risk. 19 The most relevant linked background in the research package was a Science Translational Medicine paper showing that targeted OSK expression improved aging markers in mouse models without increasing tumor incidence. 19 That is supportive preclinical context, not human efficacy evidence for ER-100 or any future chemical reprogramming pill.

Dr. Rhonda Patrick, biomedical scientist and founder of FoundMyFitness, posted the clearest protocol-level research item on July 7. She summarized a pooled randomized-trial analysis in Annals of Internal Medicine showing that cutting sleep by about 80 minutes per night for 6 weeks added roughly 1 pound of body weight and 0.5 cm of waist circumference. 4 Columbia University Irving Medical Center described the same study as a randomized crossover analysis of 95 adults with increased cardiometabolic risk, recruited in the New York City metro area between 2016 and 2023. 20

The measured changes were modest but concrete: sleep restriction reduced average sleep to 367.5 minutes versus 445.8 minutes in the adequate-sleep phase, increased body weight by 0.45 kg, increased waist circumference by 0.52 cm, and increased sedentary time by 17 minutes per day. 20 Marie-Pierre St-Onge, the study's senior author at Columbia, said adequate sleep may help reduce risk of weight gain and obesity-related conditions such as heart disease and diabetes. 20

Patrick's flavanol posts were the cleanest diet signal. On July 8, she wrote that only 20% of people who meet 5-servings-per-day fruit-and-vegetable guidelines reach an estimated 500 mg/day of flavanols, a level associated with lower cardiovascular-disease risk in randomized studies. 9 The underlying Food & Function paper was summarized by EMJ, which reported that green tea, apples, berries, and cocoa are major flavanol sources. 21

Patrick also prevented the easy misreading. A follow-up post said the finding is "not" a reason to neglect fruits and vegetables, because the 5-a-day guideline was never designed specifically around flavanol intake. 22 That makes the practical recommendation simple: keep the fruit-and-vegetable baseline, then deliberately include flavanol-rich foods if the goal is the 500 mg/day range discussed in the studies.

Her bone-broth post was more personal but still protocol-like. Patrick said she used bone broth after international travel, time-zone changes, and disrupted sleep, and she described it as a source of warm fluids, protein, collagen-derived gelatin, glycine, and proline. 10 The recipe used 2-3 pounds of beef bones, ginger, turmeric, apple cider vinegar, onion, garlic, black peppercorns, bay leaves, sea salt, and 8-10 cups of water, with bones roasted at 400°F for 30 minutes and then slow-cooked for 12-24 hours. 10 The important caveat is that Patrick framed it alongside sleep, hydration, sunlight, and taking it easy, not as a standalone recovery hack. 10

FoundMyFitness also published a July 5-6 Science Digest covering 3 areas: visceral-fat reduction and type 2 diabetes risk, sleep regularity and mortality, and blood-flow restriction training after cycling sprints. 11 The sleep-regularity item is the one that best connects to the rest of the week: in more than 60,000 UK Biobank participants followed for about 8 years, the most regular sleepers had 20-30% lower all-cause mortality and 31-38% lower cardiometabolic mortality than the least regular sleepers. 11

Peter Attia, physician and host of The Peter Attia Drive, did not publish a new numbered podcast episode in the window. The feed instead surfaced AMA #71, a rebroadcast on building strength and muscle mass that originally appeared as episode #349. 12 The rebroadcast covered muscle mass, strength, cardiorespiratory fitness, grip strength, progressive overload, explosive power, protein, creatine, and training adjustments for beginners, older adults, and experienced lifters. 12

The week's new Attia material was a July 11 free article by Nicholas Nelson, Michael Rae, and Attia on sleep and lifespan. 5 The article examined a GeroScience meta-analysis of 79 observational studies that associated sleeping less than 7 hours with 14% higher all-cause mortality and sleeping more than 9 hours with 34% higher all-cause mortality. 5

Attia's team argued that those observational numbers cannot be treated as personal risk estimates because they do not separate short sleep causing disease from disease causing short sleep. 5 The article put the limitation in one sentence: "This study cannot tell us how much of that 14% increase in mortality is caused by a lack of sleep and not by diseases that cause people to lose sleep." 5

The better evidence, in Attia's framing, comes from short-term experiments. His team cited a controlled experiment in which one night of total sleep loss raised cortisol by 21%, lowered testosterone by 24%, and cut muscle protein synthesis rate by 18%. 5 They also cited a 2-week dieting study in which participants sleeping 5.5 hours per night lost about 60% of their weight from lean mass rather than fat. 5

That creates a useful distinction next to Patrick's sleep posts. Patrick's material gives a behaviorally actionable warning about modest chronic sleep restriction. Attia's article tells readers not to panic over an occasional bad night or overinterpret mortality percentages from observational research. His closing line captured the balance: "don't lose sleep over losing sleep now and then." 5

There was no strong cross-expert convergence on a single intervention this week. Johnson was in autoimmune disease and individualized immune engineering; Sinclair was in fasting, sirtuins, clocks, and reprogramming; Patrick was in practical sleep, nutrition, and recovery; Attia was in sleep-methodology critique. The connective tissue was evidence quality.

The shared topic with the best source support was sleep. Patrick's cited trial data showed that losing about 80 minutes of sleep per night for 6 weeks moved weight, waist circumference, and sedentary time in the wrong direction. 4 Attia's article argued that observational mortality percentages are too confounded to become personal risk numbers, while short-term experimental sleep-loss studies still show causal harm to endocrine, metabolic, and body-composition markers. 5 The combined action is boring and useful: protect sleep regularity and duration, but do not turn one bad night into a new anxiety loop.

The main uncertainty sits with Johnson and Sinclair. Johnson's plan is unusually detailed, but the therapy paths are personalized and experimental. Sinclair's fasting advice includes usable timing concepts, but his resveratrol, sirtuin, clock, and OSK posts mainly reinforce positions he already holds. 168

For personal adoption, the order of operations is clear. First, review persistent unexplained symptoms with a clinician rather than assuming self-tracking will catch everything. Second, fix low-regret basics that appeared across multiple sources: sleep duration, sleep timing, resistance training, flavanol-rich foods, hydration, and recovery. Third, keep engineered immune therapies, chemical reprogramming, and supplement defenses in the watchlist category until public human data catches up to the claims.